Medico Oncologo
Joined May 2012
- Tweets 3,249
- Following 331
- Followers 817
- Likes 5,099
450 Photos and videos
🎯Capivasertib abiraterona/prednisona aprobado por la FDA para el #cáncerPróstatametastásico con deficiencia de #PTEN.
2
3
119
🎯Gran reunión Urooncologia #SociedadEcuatorianaOncologia #SociedadEcuatorianaUrologia #capróstata opciones terapéutica
7
102
Rodrigo Sanchez Roger retweeted
Jun 11
⚡️ NEMIO trial published in @JCO_ASCO: neoadjuvant ddMVAC durvalumab in cisplatin-eligible MIBC (n=121).
pCR 47.8%. Adding tremelimumab yields similar pCR but worse toxicity.
Chemoimmunotherapy in the neoadjuvant setting: durvalumab adds value, tremelimumab does not.
ascopubs.org/doi/10.1200/JCO…
#BladderCancer #Immunotherapy
1
15
26
2,513
4
76
Rodrigo Sanchez Roger retweeted
🎉 ¡Hito para @Blatam_urology ! 🎉
🏥 Hoy celebramos la inclusión del 1° paciente enrolado en el estudio BLATAM #NMIBC.
🔬 Cada paciente🧍cuenta. Cada dato suma. Cada estudio acerca nuevas oportunidades para nuestros pacientes
#InvestigaciónClínica #CáncerVejiga #PrimerPaciente
1
8
21
428
Rodrigo Sanchez Roger retweeted
This is a very interesting finding in PROTEUS. pN1 rates similar in both arms, so adding ARPI did not eradicate much extra small-volume metastatic disease. Not very encouraging for ARPI in intact prostate RT. But perhaps another important scientific contribution from this trial.
Jun 3
Can you help with an issue I can't grasp? If the primary endpoint of local pathological complete response or minimal residual disease is potentially clinically significant why was there no difference in histopathological lymph nodes? Is this typical of neoadjuvant trials?
4
7
29
8,509
Rodrigo Sanchez Roger retweeted
Contacto
urooncologia.arg@gmail.com
2
2
50
🎯 Highlights of the Year in Melanoma and Skin Cancer👏👏👏 @aaoncoclinica @SauUrologia @Martin_AngelMD @oncourologiaarg #Melanoma #Chacon @fundacion_FUCA
4
12
614
Rodrigo Sanchez Roger retweeted
One of the most thought-provoking slides at #ASCO26. Dr. Reimers outlines a future MIBC paradigm where cCR, ctDNA and utDNA guide decisions between cystectomy, bladder preservation and surveillance after EV pembrolizumab. Smarter treatment, less overtreatment. #ASCO26 @OncoAlert
1
15
30
1,817
Rodrigo Sanchez Roger retweeted
Gran sesión de #Melanoma en #ASCO26 coordinada por Dr. Matías Chacon 🇦🇷 @fundacion_FUCA @IAF_Fleming @aaoncoclinica @ProfGLongMIA
Orgullo 🇦🇷!!
1
5
21
570
Rodrigo Sanchez Roger retweeted
May 31
A summary for today’s GU sessions and Plenary
Do not miss it !! #asco2026
@MedscapeOnc @oncodaily @OncoDailyGU @OncoAlert @feresparza06 @Elias31222749
1
10
17
787
Rodrigo Sanchez Roger retweeted
May 31
@GUconference transforms scientific exchanges among med oncologists, rad oncs, and urologist into . . well. . a rhinestone-studded country-music infused affair. So engaging it won award for best new medical conf format & best belt buckles. Dec 3-5
#ASCO26
@CaPsurvivorship
1
1
79
Rodrigo Sanchez Roger retweeted
May 31
Final analysis of the PROTEUS phase 3 study‼️ Mary Ellen Taplin
⬆️ pCR or MRD was significantly higher in the apalutamide group (8.9% vs. 1.0%; P<0.001)
✅ 5 Years MFS , 78.2% vs. 73.5%; P=0.02) #ASCO26 #plenarysession
Are we ready to change practice ⁉️
2
4
6
1,043
Rodrigo Sanchez Roger retweeted
May 31
The new algorithm in HR licalized prostate cancer
@declangmurphy #ASCO26
4
7
223
Rodrigo Sanchez Roger retweeted
May 31
Excellent presentation by @declangmurphy at plenay session #ASCO26
#Proteus will be a new standard of care!
Múltiple patients focused end points that improve QoL!
6
9
539
🎯Ansioso esperando #plenaria vamos a estar grabando⏰🔈 #Proteus y la principales novedades de GU @aaoncoclinica @GrupoGuiaArg @oncourologiaarg
5
16
410
Rodrigo Sanchez Roger retweeted
May 31
The #AI Intersection: Evaluating Its Impact on Patients, Trainees, and Global Practice #ASCO26
#digitalhealth
3
5
148
Rodrigo Sanchez Roger retweeted
May 31
@drteplinsky Great conclusion ‼️
🤔 What are we doing to avoid this?
#ASCO26 #digitalhealth #AAOCDigital
3
7
243